ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bethea, M
Right arrow Articles by Forman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bethea, M
Right arrow Articles by Forman, D.
Annals of Clinical and Laboratory Science, Vol 20, Issue 3, 163-168
Copyright © 1990 by Association of Clinical Scientists

Articles

Beta 2-microglobulin: its significance and clinical usefulness

M Bethea and DT Forman

beta 2-Microglobulin (beta 2M), an interesting and underutilized metabolite, can be used in assessing renal function, particularly in kidney-transplant recipients and in patients suspected of having renal tubulointerstitial disease. It also can serve as a nonspecific but relatively sensitive marker of various neoplastic, inflammatory, and infectious conditions. Early hopes that it would be a useful serum test for malignancy have not been fulfilled, but it does have prognostic value for patients with lymphoproliferative disease, particularly multiple myeloma. More recent reports have suggested a role for beta 2M as a prognostic marker in human immunodeficiency virus (HIV) infection.


This article has been cited by other articles:


Home page
 BloodHome page
K. Matsushita, I. Margulies, M. Onda, S. Nagata, M. Stetler-Stevenson, and R. J. Kreitman
Soluble CD22 as a tumor marker for hairy cell leukemia
Blood, September 15, 2008; 112(6): 2272 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Gross, I. Top, I. Laux, J. Katz, J. Curran, C. Tindell, and D. Agus
{beta}-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer
Clin. Cancer Res., April 1, 2007; 13(7): 1979 - 1986.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
S. S. Dickerson, M. E. Kemeny, N. Aziz, K. H. Kim, and J. L. Fahey
Immunological Effects of Induced Shame and Guilt
Psychosom Med, January 1, 2004; 66(1): 124 - 131.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Gatto, G. Ball, F. Onida, H. M. Kantarjian, E. H. Estey, and M. Beran
Contribution of {beta}-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)
Blood, September 1, 2003; 102(5): 1622 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Filler, F. Priem, N. Lepage, P. Sinha, I. Vollmer, H. Clark, E. Keely, M. Matzinger, A. Akbari, H. Althaus, et al.
{beta}-Trace Protein, Cystatin C, {beta}2-Microglobulin, and Creatinine Compared for Detecting Impaired Glomerular Filtration Rates in Children
Clin. Chem., May 1, 2002; 48(5): 729 - 736.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Association of Clinical Scientists.